Zheng Fu-fu, Dai Yu-ping, Luo Dao-sheng, Liang Yue-you, Deng Chun-hua, Chen Wei, Chen Ling-wu, Li Xiao-fei, Qiu Shao-peng, Zheng Ke-li
Department of Urology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Zhonghua Wai Ke Za Zhi. 2008 Jun 1;46(11):829-31.
To study the diagnosis and treatment of renal cell carcinoma.
From January 1993 to December 2000 the data of 271 cases of renal cell carcinoma were reviewed.
Ultrasonography and CT scanning were still the main diagnostic methods. Surgical operation was performed on 234 patients. Radical nephrectomy was performed on 197 patients (72.6%); Nephron sparing surgery was performed on 19 patients; Metastatic tumor resection was performed on 6 patients and other procedures for 12. The pathological results showed that 137 cases (61.4%) were clear cell carcinoma, 18 cases (8. 1%) of granular cell carcinoma, 32 cases (14. 3%) being combination of the above two varieties, 23 cases (10.3%) of renal papillary adenocarcinoma, 13 cases being renal cell of other types. And 210 cases (77.5%) had been successfully followed up. The 1, 3, 5 and 10 year survival rates were 95.3% (182/191), 88.7% (107/122), 74.7% (56/75) and 32.1% (10/31) respectively.
Ultrasonography is the first select examination method of detecting of renal cell carcinoma, and CT scanning is the most valuable diagnostic mean. Early diagnosis and prompt radical nephrectomy or nephron sparing nephrectomy are the critical points for achieving long-term survivals of patients with renal cell carcinoma.
研究肾细胞癌的诊断与治疗。
回顾1993年1月至2000年12月期间271例肾细胞癌患者的数据。
超声检查和CT扫描仍是主要诊断方法。234例患者接受了手术治疗。197例（72.6%）患者行根治性肾切除术；19例患者行保留肾单位手术；6例患者行转移性肿瘤切除术，12例患者行其他手术。病理结果显示，137例（61.4%）为透明细胞癌，18例（8.1%）为颗粒细胞癌，32例（14.3%）为上述两种类型的组合，23例（10.3%）为肾乳头状腺癌，13例为其他类型肾细胞癌。210例（77.5%）患者获得成功随访。1年、3年、5年和10年生存率分别为95.3%（182/191）、88.7%（107/122）、74.7%（56/75）和32.1%（10/31）。
超声检查是肾细胞癌检测的首选检查方法，CT扫描是最有价值的诊断手段。早期诊断并及时行根治性肾切除术或保留肾单位肾切除术是肾细胞癌患者获得长期生存的关键。
